Avance Clinical Showcases Early Phase Expertise and the Australian Advantage for EU Biotechs at BIO-Europe Vienna
Helping European Biotechs Accelerate Early Phase Success With Faster Timelines, Lower Costs, and Globally Accepted Data
Search results
We found 173 results for: “phase ii”
Avance Clinical Launches Dedicated Center of Excellence to Accelerate Early Phase Biotech Trials
Avance Clinical today announced the launch of its dedicated Early Phase Center of Excellence for Biotechs
Early Phase Center of Excellence for Biotechs
Avance Clinical has launched its Early Phase Center of Excellence for Biotechs, designed to deliver scientific rigor, innovative trial design, global regulatory insight, and operational excellence for smarter, more efficient early phase trials with significant cost savings for biotechs worldwide.
Cut Timelines and Costs in Late-Phase Oncology: Why Asia Should Be Your Next Trial Destination
Globally, cancer diagnoses are projected to reach 35.3 million new cases per year with death rates rising to 18.5 million by 2050.²
Avance Clinical Partners with China Medical University Hospital in Taiwan to Strengthen Early-to-Late Phase Clinical Trial Pathway
CMUH is renowned for its excellence in conducting clinical trials, and Avance Clinical specializes in early-phase clinical researchers.
Avance Clinical Leads as the CRO of Choice for Early Phase Clinical Trials in Australia – Announced at Biotech Showcase 2025
Avance Clinical, a leading full-service global Contract Research Organization (CRO) known for delivering high-quality, agile clinical research services, is proud to announce it is the CRO of choice for early phase clinical trials in Australia.
Clinical Leader Solutions Expo: Early-Phase Oncology Trials (CRO)
Discover an informative webinar that delves into the strategic benefits of conducting early-phase oncology clinical development across Australia and the USA.
Clinical Leader Solutions Expo: Early-Phase Oncology Trials (CRO)
As small and emerging biopharma companies now lead 70% of trial starts, navigating the complexities of early-phase oncology trials requires the support of expert CRO partners.
Strategic Advantages of Early-Phase Oncology Clinical Development Across Australia and the USA
Oncology has been and continues to be the leading priority in global drug development. 44% of all Phase I-III trials, current and planned, are tackling oncology. But as the push to combat cancer evolves, so too has the drug development arena. In the last decade, ...
Phase II / Late Phase
As your drug development journey progresses, the Avance Clinical team can transition your clinical research from early to late phase multi-regional studies with the assurance that the global team brings the same expertise and professionalism you have come to expect. All the while saving time ...